About pre-mRNA splicing regulator USH1G
pre-mRNA splicing regulator USH1G (USH1G) is a protein
from Homo sapiens identified by UniProt accession
Q495M9, 461 residues long.
MolForge cross-references it against 0 known binders and
49 disease associations.
Target properties
| Protein name | pre-mRNA splicing regulator USH1G |
| UniProt accession | Q495M9 |
| Gene | USH1G |
| Organism | Homo sapiens |
| Length | 461 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (49)
Diseases linked to this target (Open Targets).
- Usher syndrome type 1 · score 0.68
- Usher syndrome · score 0.55
- deafness · score 0.48
- Hearing impairment · score 0.43
- hearing loss · score 0.37
- hearing loss, autosomal recessive · score 0.32
- Rare genetic deafness · score 0.27
- genetic disorder · score 0.19
- autism · score 0.08
- Asperger syndrome · score 0.07
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q495M9-F1 | alphafold | PREDICTED | 68.25 | — |
Amino-acid sequence (461 residues)
MNDQYHRAAR DGYLELLKEA TRKELNAPDE DGMTPTLWAA YHGNLESLRL IVSRGGDPDK CDIWGNTPLH LAASNGHLHC LSFLVSFGAN IWCLDNDYHT PLDMAAMKGH MECVRYLDSI AAKQSSLNPK LVGKLKDKAF REAERRIREC AKLQRRHHER MERRYRRELA ERSDTLSFSS LTSSTLSRRL QHLALGSHLP YSQATLHGTA RGKTKMQKKL ERRKQGGEGT FKVSEDGRKS ARSLSGLQLG SDVMFVRQGT YANPKEWGRA PLRDMFLSDE DSVSRATLAA EPAHSEVSTD SGHDSLFTRP GLGTMVFRRN YLSSGLHGLG REDGGLDGVG APRGRLQSSP SLDDDSLGSA NSLQDRSCGE ELPWDELDLG LDEDLEPETS PLETFLASLH MEDFAALLRQ EKIDLEALML CSDLDLRSIS VPLGPRKKIL GAVRRRRQAM ERPPALEDTE L
Explore pre-mRNA splicing regulator USH1G with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets